Table 1.
Lysine-acetylated β peptides identified from glucose-exposed wild-type cells | |||||||
---|---|---|---|---|---|---|---|
Sequence | Prob | SEQUEST XCorr |
SEQUEST ΔCn |
Observed Precursor m/z |
Actual Peptide Mass (MW) |
Charge | Delta PPM |
(R)DNK236(+42)LQmELVPER(L) | 95% | 2.955 | 0.481 | 510.5923 | 1528.76 | 3 | −0.4136 |
(R)QLEK279(+42)DDVK(L)* | 95% | 2.407 | 0.4241 | 508.7665 | 1015.52 | 2 | −0.3027 |
(K)VTPK890(+42)GETQLTPEEK(L) | 95% | 3.296 | 0.6551 | 799.9181 | 1597.82 | 2 | 0.8714 |
(R)AIFGEK909(+42)ASDVK(D)* | 95% | 3.424 | 0.6959 | 603.8215 | 1205.63 | 2 | −0.7829 |
(K)ASDVK914(+42)DSSLR(V)* | 95% | 3.105 | 0.3712 | 560.2856 | 1118.56 | 2 | −0.08906 |
(R)ALEIEEmQLK954(+42)QAK(K) | 95% | 3.883 | 0.6378 | 786.9191 | 1571.82 | 2 | 0.2837 |
(R)AVLVAGGVEAEK988(+42)LDK(L) | 95% | 4.315 | 0.7414 | 770.9325 | 1539.85 | 2 | −0.3886 |
(K)LDK991(+42)LPR(D)* | 95% | 1.741 | 0.3937 | 392.2397 | 782.4648 | 2 | −0.5344 |
(R)K1035(+42)ITQGDDLAPGVLK(I) | 95% | 3.136 | 0.5483 | 748.9197 | 1495.82 | 2 | −0.07396 |
(R)mNIGQILETHLGmAAK1122(G) | 95% | 3.105 | 0.4271 | 600.9708 | 1799.89 | 3 | −0.3436 |
(K)INAmLK1133(+42)QQQEVAK(L) | 95% | 4.660 | 0.6422 | 779.9177 | 1557.82 | 2 | 1.362 |
(K)QQQEVAK1140(+42)LR(E)* | 95% | 2.559 | 0.5444 | 571.3196 | 1140.62 | 2 | −0.4438 |
(R)K1178(+42)GmPIATPVFDGAK(E) | 95% | 3.851 | 0.6688 | 745.3899 | 1488.77 | 2 | 0.1888 |
(K)ELLK1200(+42)LGDLPTSGQIR(L) | 95% | 4.029 | 0.5342 | 841.4792 | 1680.94 | 2 | 1.418 |
(R)STGSYSLVTQQPLGGK1262(+42) AQFGGQR(F) | 95% | 4.335 | 0.5947 | 803.744 | 2408.21 | 3 | 0.543 |
Lysine-acetylated β’ peptides identified from glucose-exposed wild-type cells | |||||||
Sequence | Prob | SEQUEST XCorr | SEQUEST ΔCn | Observed Precursor m/z | Actual Peptide Mass (MW) | Charge | Delta PPM |
(K)AQTK13(+42)TEEFDAIK(I)* | 95% | 3.134 | 0.5511 | 711.8596 | 1421.70 | 2 | 0.4564 |
(K)K40(+42)PETINYR(T) | 95% | 1.857 | 0.3906 | 531.7829 | 1061.55 | 2 | 0.5715 |
(R)GLATTIK395(+42)AAK(K) | 95% | 2.728 | 0.654 | 508.3111 | 1014.61 | 2 | 0.1017 |
(K)GEGmVLTGPK531(+42)EAER(L) | 95% | 3.620 | 0.5413 | 766.3754 | 1530.74 | 2 | 0.8169 |
(K)TSLK570(+42)DTTVGR(A) | 95% | 2.799 | 0.4491 | 560.3032 | 1118.59 | 2 | −1.289 |
(R)SGASVGIDDmVIPEK649(+42)K(H) | 95% | 3.297 | 0.5722 | 852.4306 | 1702.85 | 2 | 0.9404 |
(R)AAAESSIQVK953(+42)NK(G) | 95% | 3.437 | 0.5779 | 644.3492 | 1286.68 | 2 | 0.6021 |
(K)GSIK959(+42)LSNVK(S) | 95% | 2.737 | 0.5114 | 494.2947 | 986.5748 | 2 | −1.35 |
(K)LSNVK964(+42)SVVNSSGK(L) | 95% | 3.015 | 0.6372 | 680.8746 | 1359.73 | 2 | −0.8405 |
(R)NTELK983(+42)LIDEFGR(T) | 95% | 3.479 | 0.5128 | 492.9273 | 1475.76 | 3 | −1.452 |
(R)LQGVK1247(+42)INDK(H) | 95% | 1.808 | 0.2969 | 528.8063 | 1055.60 | 2 | 0.2463 |
Immunoprecipitated β and β’ proteins were separated by SDS-PAGE and β and β’ bands were digested with trypsin, as described (Chi et al., 2010). The resulting peptides were analyzed in a LTQ OrbitrapXL™ mass spectrometer, as described in the Methods section and analyzed using the Scaffold software. The table shows the Xcorr, ΔCn scores, charges, both the observed precursor m/z and actual peptide mass, and the mass deviation (delta ppm) of all 15 K-acetylated peptides detected for β and 11 K-acetylated peptides detected for β’ in the glucose-exposed samples. In these tables, the CID MS/MS spectra of the acetylated β and β’ peptides are shown in Tables S1 and S2, respectively. The complete b and y ion series are cognizable and labelled in red and blue, respectively. Acetylated peptides detected in at least two biological replicates are underlined.
An asterisk indicates acetylated peptides identified in samples collected from glucose-exposed yfiQ mutants (Supplemental Tables S6 and S7). None of these peptides was detected in the absence of glucose (Supplemental Tables S4, S5, S9 and S10).